Bayesian Capital Management’s Ambrx Biopharma Inc AMAM Stock Holding History

Bayesian Capital Management’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,804	Closed	-$225K	–	1193
2023 Q4	$225K	Buy	+15,804	New	+$180K	0.02%	574

Bayesian Capital Management's AMAM Position: Q1 2024 in Review

Bayesian Capital Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 15,804 shares — an estimated $225K sold.

Bayesian Capital Management first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $225K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Bayesian Capital Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Bayesian Capital Management sold 15,804 Ambrx Biopharma Inc shares in Q1 2024, an estimated $225K.
Bayesian Capital Management first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Bayesian Capital Management's Ambrx Biopharma Inc position peaked at $225K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Bayesian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.